Abstract
CAR is a transmembrane protein that is expressed in various epithelial and endothelial cells. CAR mediates adenoviral infection, as well as adenovirus-mediated oncolysis of AxdAdB-3, an E1A/E1B double-restricted oncolytic adenovirus, in prostate cancer cells. This study further assessed the therapeutic efficacy of AxdAdB-3 with Arg-Gly-Asp (RGD)-fiber modification (AxdAdB3-F/RGD), which enables integrin-dependent infection, in prostate cancer. Susceptibility of prostate cancer cells LNCaP, PC3, and DU145 to adenovirus infection was associated with CAR expression. All of the prostate cancer cell lines expressed integrin αvβ3 and αvβ5. AxdAdB-3 was more cytopathic in CAR-positive prostate cancer cells than in CAR-negative cells, whereas AxdAdB3-F/RGD caused potent oncolysis in both CAR-positive and CAR-negative prostate cancer cells. In contrast, AxdAdB3-F/RGD was not cytopathic against normal prostate epithelial cells, RWPE-1. Intratumoral injection of AxdAdB3-F/RGD into CAR-negative prostate cancer cell xenografts in nude mice inhibited tumor growth. The current study demonstrates that E1A/E1B double-restricted oncolytic adenovirus with an RGD-fiber modification enhances infection efficiency and anti-tumor activity in CAR-defic...Continue Reading
References
Oct 11, 1995·Nucleic Acids Research·Y KanegaeI Saito
Jan 1, 1993·The Prostate·A G CarrollE P Gelmann
Jun 11, 1999·Journal of Virology·J N Harada, A J Berk
Oct 4, 2000·Nature Medicine·C HeiseD Kirn
Dec 19, 2002·Cancer Gene Therapy·Hironari DehariHirofumi Hamada
Mar 12, 2004·Oncogene·Candelaria Gomez-ManzanoJuan Fueyo
Oct 8, 2004·The New England Journal of Medicine·Ian F TannockUNKNOWN TAX 327 Investigators
Mar 1, 2005·Oncogene·Masaki TakiToshiyoshi Fujiwara
May 17, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mariko WakayamaKazunari K Yokoyama
Dec 26, 2007·Urology·Makoto SatohYoichi Arai
Jul 3, 2008·Cell Cycle·John T LeeJames A McCubrey
Dec 4, 2008·Asian Journal of Andrology·Ling ZhangXue-Jian Zhao
May 27, 2011·The New England Journal of Medicine·Johann S de BonoUNKNOWN COU-AA-301 Investigators
Jun 2, 2011·International Journal of Cancer. Journal International Du Cancer·Sari PesonenAkseli Hemminki
Sep 1, 2011·European Urology·Jerome P Richie
Nov 15, 2011·The Journal of Urology·Patrick C Walsh
Apr 25, 2012·Prostate Cancer·Teresa Maria Santos AmaralLuis Costa
Jul 14, 2012·Human Gene Therapy·Virginie AdamGunnel Halldén
Aug 17, 2012·The New England Journal of Medicine·Howard I ScherUNKNOWN AFFIRM Investigators
Sep 12, 2013·British Journal of Cancer·M ReehM Anders
May 20, 2014·International Journal of Radiation Oncology, Biology, Physics·Svend O FreytagBenjamin Movsas
May 23, 2014·Gene Therapy·Y-F YangL-S Wang
Aug 6, 2014·Human Gene Therapy·Wenliang DongVictor W van Beusechem
Oct 13, 2014·Annals of Diagnostic Pathology·Katharina HeßChristoph Röcken
Jan 7, 2015·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Citations
Mar 12, 2016·Expert Opinion on Drug Delivery·A-Rum YoonChae-Ok Yun
Feb 10, 2017·Human Gene Therapy·Rodrigo Esaki TamuraBryan E Strauss
Feb 23, 2019·Human Gene Therapy·Hongyan LiuTao Hung
Apr 25, 2019·BMC Biotechnology·Yun LvZhuo-Zhuang Lu
Sep 14, 2017·Molecular Medicine Reports·Zhonglin CaiFenghai Zhou
Oct 26, 2018·Molecular Pharmaceutics·Claudia A J van WinkelDavid T Curiel